QR Code

Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Benjian Gao,1,2,* Fengyi Yang,1,2,* Dongning Zheng,1,2 Shuai Hu,1,2 Jie Liu,1,2 Hong Liu,1,2 Yongfa Liu,1,2 LinXin Liu,1,2 Rui Wang,1,2 Yi Zhao,1,2 Cheng Cui,1,2 Cheng Fang,1,2 Jin Yang,1,2 Song Su,1,2 Yunwei Han,3 Xiaoli Yang,1,2 Bo Li1,2 1Department of General Surgery (Hepatopancreatobilia...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Gao B, Yang F, Zheng D, Hu S, Liu J, Liu H, Liu Y, Liu L, Wang R, Zhao Y, Cui C, Fang C, Yang J, Su S, Han Y, Yang X, Li B
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Dove Medical Press 2023-12-01
Rangatū:Journal of Hepatocellular Carcinoma
Ngā marau:
hepatocellular carcinoma
transarterial chemoembolization
tyrosine kinase inhibitors
immune checkpoint inhibitors
efficacy
Urunga tuihono:https://www.dovepress.com/transarterial-chemoembolization-combined-with-tyrosine-kinase-inhibito-peer-reviewed-fulltext-article-JHC
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite